Canine TK1 antibody and antigen (recombinant protein)
Diagnostic anti-Canine TK1 antibodies pairs and antigen for animal health (animal Dog/Canine hematological malignancies) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT
Go to Neurodegenerative diseases diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-CAN-TK1-Ag01 | Recombinant Canine TK1 protein | 3090 |
GMP-CAN-TK1-Ab01 | Anti-Canine TK1 mouse monoclonal antibody (mAb) | 1953 |
GMP-CAN-TK1-Ab02 | Anti-Canine TK1 mouse monoclonal antibody (mAb) | 1953 |
GMP-CAN-TK1-Ab03 | Anti-Canine TK1 human monoclonal antibody (mAb) | 1953 |
GMP-CAN-TK1-Ab04 | Anti-Canine TK1 human monoclonal antibody (mAb) | 1953 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. of Products | GMP-CAN-TK1-Ag01 |
Product Name | Recombinant Canine TK1 protein |
Target/Biomarker | Canine Thymidine Kinase 1 (S100-A9) |
Expression platform | E.coli |
Isotypes | Recombinant Antigen |
Bioactivity validation | Anti-Canine Thymidine Kinase 1 antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in S100-A9 level test of animal Dog/Canine with hematological malignancies. |
Tag | His |
Products description | Recombinant Canine TK1 protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-CAN-TK1-Ab01, GMP-CAN-TK1-Ab02 |
Product Name | Anti-Canine TK1 mouse monoclonal antibody (mAb) |
Target/Biomarker | Canine Thymidine Kinase 1 (S100-A9) |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Recombinant Canine Thymidine Kinase 1 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-S100-A9 antibodies in S100-A9 level test of animal Dog/Canine with hematological malignancies. |
Tag | mFc |
Products description | Anti-Canine TK1 mouse monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-S100-A9 antibodies. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-CAN-TK1-Ab03, GMP-CAN-TK1-Ab04 |
Product Name | Anti-Canine TK1 human monoclonal antibody (mAb) |
Target/Biomarker | Canine Thymidine Kinase 1 (S100-A9) |
Expression platform | CHO |
Isotypes | Human IgG1 |
Bioactivity validation | Recombinant Canine Thymidine Kinase 1 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-S100-A9 antibodies in S100-A9 level test of animal Dog/Canine with hematological malignancies. |
Tag | hFc |
Products description | Anti-Canine TK1 human monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-S100-A9 antibodies. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker information
Thymidine Kinase 1 (TK1) is an enzyme that holds critical importance in canine health, particularly in the sphere of DNA synthesis and cell proliferation. This biomarker is an essential player in the intricate process of DNA replication, facilitating the phosphorylation of thymidine, a nucleoside crucial for constructing DNA molecules. TK1's enzymatic activity ensures the availability of nucleotides required for DNA replication, a fundamental process in cell division and growth. In dogs, TK1 is released into the bloodstream, where its levels can be quantified through blood tests. Elevated levels of TK1 often indicate increased cellular proliferation, which can occur in various medical conditions. While TK1 is not specific to any particular disease, its elevation can signal the presence of underlying health issues, such as cancer or certain viral infections. TK1 serves as a dynamic and responsive biomarker, reflecting changes in cellular activity. In cancer, for instance, the uncontrolled growth and division of cells lead to higher TK1 levels in the bloodstream. Consequently, monitoring TK1 can offer valuable insights into the proliferative status of cells, aiding in disease diagnosis, staging, and treatment assessment.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Comments
No comments yet.